ArticleTheranostics2021
Structurally symmetric near-infrared fluorophore IRDye78-protein complex enables multimodal cancer imaging.
Open access · goldAbstract read
In one paragraph
Article in Theranostics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 22 citations in OpenAlex.
- Label-free streamlined photoacoustic image guidance facilitates NIR-II photoablation in models of melanoma lung metastases.The Journal of clinical investigation · 2026Article
- Dual-modality theranostics probes: sintegrative strategies for precision management of oncologic malignancies.Life medicine · 2026Review
- Rational design of a NIR fluorescent probe for highly selective sensing of NAD(P)H quinone oxidoreductase 1 in living systems.Frontiers in chemistry · 2025Article
- Review of Clinically Assessed Molecular Fluorophores for Intraoperative Image Guided Surgery.Molecules (Basel, Switzerland) · 2024Review
- Multimodal optoacoustic imaging: methods and contrast materials.Chemical Society reviews · 2024Review
- Water-Soluble Small Organic Fluorophores for Oncological Theragnostic Applications: Progress and Development.Topics in current chemistry (Cham) · 2024Review
- Preoperative PET imaging and fluorescence-guided surgery of human glioblastoma using dual-labeled antibody targeting ETTheranostics · 2024Article
- Unraveling the Chemistry ofACS bio & med chem Au · 2022Article
- Monosaccharide-mediated rational synthesis of a universal plasmonic platform with broad spectral fluorescence enhancement for high-sensitivity cancer biomarker analysis.Journal of nanobiotechnology · 2022Article
- Biomedical Applications of Lanthanide Nanomaterials, for Imaging, Sensing and Therapy.Nanotheranostics · 2022Review
- Multimodal Contrast Agents for Optoacoustic Brain Imaging in Small Animals.Frontiers in bioengineering and biotechnology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 4 institutions in 2 countries.
Jiang YangState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510006, China.
Chunhua ZhaoState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510006, China.
Jacky LimSchool of Chemistry and Materials Science, Rochester Institute of Technology, Rochester 14623, NY, USA.
Lina ZhaoCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China.
Ryan Le TourneauSchool of Chemistry and Materials Science, Rochester Institute of Technology, Rochester 14623, NY, USA.
Qize ZhangDepartment of Radiology, Center for Molecular Imaging and Nanotechnology (CMINT), Memorial Sloan Kettering Cancer Center, New York 10065, NY, USA.
Damien DobsonSchool of Chemistry and Materials Science, Rochester Institute of Technology, Rochester 14623, NY, USA.
Suhasini JoshiDepartment of Chemical Biology, Sloan Kettering Institute, New York 10065, NY, USA.
Jiadong PangState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510006, China.
Xiaodong ZhangDepartment of Physics, Tianjin Key Laboratory of Low Dimensional Materials Physics and Preparing Technology, Tianjin Collaborative Innovation Center of Chemical Science and Engineering, Tianjin University, Tianjin 300354, China.
Suchetan PalDepartment of Radiology, Center for Molecular Imaging and Nanotechnology (CMINT), Memorial Sloan Kettering Cancer Center, New York 10065, NY, USA.
Chrysafis AndreouDepartment of Radiology, Center for Molecular Imaging and Nanotechnology (CMINT), Memorial Sloan Kettering Cancer Center, New York 10065, NY, USA.
Hanwen ZhangDepartment of Radiology, Center for Molecular Imaging and Nanotechnology (CMINT), Memorial Sloan Kettering Cancer Center, New York 10065, NY, USA.
Moritz F KircherDepartment of Radiology, Center for Molecular Imaging and Nanotechnology (CMINT), Memorial Sloan Kettering Cancer Center, New York 10065, NY, USA.
Hans SchmitthennerSchool of Chemistry and Materials Science, Rochester Institute of Technology, Rochester 14623, NY, USA.
Sun Yat-sen University · CNInstitute of High Energy Physics · CNSun Yat-sen University Cancer Center · CNUniversity of Cyprus · CY
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4MUltrabright Theranostic SERRS Nanoparticles for Gastrointestinal EndoscopyR01CA222836 · NCI · STANFORD UNIVERSITY · PI ROGALLA, STEPHAN · 2018 to 2023
$3.4MMRI-Photoacoustic-Raman Nanostars for Pre- and Intraoperative Multimodal ImagingR01EB017748 · NIBIB · SLOAN-KETTERING INST CAN RESEARCH · PI KIRCHER, MORITZ FLORIAN · 2014 to 2017
$1.6MHigh Relaxivity PSMA-Targeted Contrast Agents for MRI of Prostate CancerR15CA219915 · NCI · ROCHESTER INSTITUTE OF TECHNOLOGY · PI SCHMITTHENNER, HANS F. · 2018 to 2020
$570kTargeted Molecular Agents for Photoacoustic Imaging of Prostate CancerR15CA192148 · NCI · ROCHESTER INSTITUTE OF TECHNOLOGY · PI SCHMITTHENNER, HANS F. · 2014 to 2014
$444kNCI NIH HHS P30 CA008748NCI NIH HHS R01 CA222836NCI NIH HHS R15 CA192148NCI NIH HHS R15 CA219915NIBIB NIH HHS R01 EB017748
Abstract
PubMed holds no abstract for this paper.
Indexed as
AnimalsBrain NeoplasmsCell Line, TumorFemaleFluorescenceFluorescent DyesGlioblastomaHumansIndocyanine GreenIndolesLactalbuminMiceMice, Inbred C57BLOptical ImagingPositron-Emission TomographySpectroscopy, Near-InfraredFluorescent DyesIndocyanine GreenIndolesIRDye800Lactalbumin89Zrbreast cancercarrier proteinsglioblastomamultimodal imagingnear-infrared fluorophoresrenal clearancestructure symmetry
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.